The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

“When you inject yourself with, for example, insulin, you inject into subcutaneous fat, but these patients don’t have that,” ...

Regular insulin, which is often used in pregnancy for the treatment of diabetes, has some drawbacks: it starts its action from 30 to 60 min after subcutaneous injection and it peaks too late (2-3 ...

subcutaneous group: short acting, 24.0 and 25.5 units, respectively, and intermediate acting, 50.1 and 52.3 units, respectively). As the inhaled insulin regimen involved only one daily injection ...

Transdermal delivery of insulin is not new ... studies – delivers longer-lasting and more stable levels than subcutaneous injections, without breaking the skin layers. The prototype transdermal ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

This human insulin analogue that comes in disposable pens prefilled ... Steady state is achieved after 3–4 weekly subcutaneous injections.

Ozempic has interactions with some other drugs, such as insulin, and certain supplements. Ozempic is a solution for subcutaneous injection that’s approved by the Food and Drug Administration ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

insulin, you inject into subcutaneous fat, but these patients don't have that," said Svetlana Ten, associate professor of pediatrics and first author of the study. "Each injection is painful." ...